Loading...
Global Health Limited
GLH.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.08
A$0.00(0.00%)
Global Health Limited (GLH.AX) Financial Performance & Income Statement Overview
Review Global Health Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.90%
↑ 3.90%
Operating Income Growth
67.29%
↑ 67.29%
Net Income Growth
83.71%
↑ 83.71%
Operating Cash Flow Growth
67.28%
↑ 67.28%
Operating Margin
-14.08%
↓ 14.08%
Gross Margin
10.54%
↑ 10.54%
Net Profit Margin
-10.31%
↓ 10.31%
ROE
27.05%
↑ 27.05%
ROIC
53.41%
↑ 53.41%
Global Health Limited (GLH.AX) Income Statement & Financial Overview
Review Global Health Limited's (GLH.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $4.33M | $4.08M | $4.04M | $4.63M |
| Cost of Revenue | $3.33M | $4.20M | $4.62M | $5.05M |
| Gross Profit | $1.001M | -$114213.00 | -$575729.00 | -$410476.00 |
| Gross Profit Ratio | $0.23 | -$0.03 | -$0.14 | -$0.09 |
| R&D Expenses | $1.11M | $0.00 | $1.47M | $2.49M |
| SG&A Expenses | $390332.00 | $571531.00 | $499868.00 | $702211.00 |
| Operating Expenses | $1.50M | $571531.00 | $499868.00 | $702211.00 |
| Total Costs & Expenses | $4.83M | $4.77M | $5.12M | $5.75M |
| Interest Income | $0.00 | $6786.00 | $1875.00 | $1.00 |
| Interest Expense | $0.00 | $18843.00 | $57436.00 | $13453.00 |
| Depreciation & Amortization | $4451.00 | $4119.00 | $1735.00 | $288119.00 |
| EBITDA | -$499458.00 | -$674838.00 | -$1.07M | -$4.72M |
| EBITDA Ratio | -$0.12 | -$0.17 | -$0.27 | -$0.18 |
| Operating Income | -$499458.00 | -$685743.00 | -$1.08M | -$1.11M |
| Operating Income Ratio | -$0.12 | -$0.17 | -$0.27 | -$0.24 |
| Other Income/Expenses (Net) | -$187296.00 | -$31010.00 | -$55558.00 | -$3.91M |
| Income Before Tax | -$686754.00 | -$716753.00 | -$1.13M | -$5.02M |
| Income Before Tax Ratio | -$0.16 | -$0.18 | -$0.28 | -$1.08 |
| Income Tax Expense | $0.00 | -$535800.00 | $5.00 | $316636.00 |
| Net Income | -$686754.00 | -$180953.00 | -$1.13M | -$5.34M |
| Net Income Ratio | -$0.16 | -$0.04 | -$0.28 | -$1.15 |
| EPS | -$0.01 | -$0.003 | -$0.02 | -$0.09 |
| Diluted EPS | -$0.01 | -$0.003 | -$0.02 | -$0.09 |
| Weighted Avg Shares Outstanding | $58.05M | $58.37M | $58.05M | $58.003M |
| Weighted Avg Shares Outstanding (Diluted) | $58.05M | $58.37M | $58.05M | $58.003M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan